Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
21 Cards in this Set
- Front
- Back
What does mobility help?
|
systems function properly, respiratory, gastrointestinal, and urinary
|
|
increased cardiac workload, orthostatic hypotension, venous thombosis
|
Effects of immobility on the cardiac system
|
|
Decreased ventilator effort, pooling of respiratory secretions, altered gas exchange
|
Effects of immobility on the Respiratory system
|
|
Decreased muscle mass, tone, and strength, decreased joint mobility, bone demineralization occurs as early as 2-3
|
Effects of immobility on the Musculoskeletal system
|
|
decreased appetite, stress ulcers, decreased peristalsis, constipation, fecal impaction
|
Effects of immobility on the Digestive system
|
|
Skin shearing and pressure ulcers
|
Effects of immobility on the Integumentary system
|
|
urinary stasis, formation of kidney stones, urinary retention
|
Effects of immobility on the Urinary system
|
|
decreased metabolic rate OR increased rate S/T fever, illness, and poor nutrition
|
Effects of immobility on the metabolic function
|
|
l sleep-wake disturbances, decreased sensory stimulation, boredom, anxiety, depression, increased dependency, behavioral changes
|
Effects of immobility psychological
|
|
Fat Emboli
|
Occurs primarily after a pt has had a fx. Fat coems out of bone marrow and travels in the circulatory system to the lungs
|
|
Defining characteristics of VTE
|
Edema, extremity pain, redness or warmth following path of vein, temp greater than 100.4
|
|
Doppler Ultrasound
|
ultrasound used to document reduced blood flow
|
|
Impedance Plethysmography
|
Blood pressure cuff used to record changes in blood flow
|
|
Radionuclide Scan
|
Radioactive injection followed by scanning to localize area of obstructed blood flow.
|
|
Venography
|
Radiopaque contrast media injected through foot vein to localize thrombi in deep venous system
|
|
GIven IV or SQ, monitored with PTT
|
Heparin
|
|
Argotroban or Refludan, monitored with PTT
|
Used as an alternative to Heparin, especially in pts who have had HITT, Synthetic
|
|
Heparin Induced Thrombocytopenia (HITT)
|
Immune Response to Heparin
|
|
Low Molecular Weight Heparin, Given SQ in abdomen, No monitoring, DVT prophylaxis
|
LOVENOX
|
|
Most common oral anticoagulant, monitored with PT/INR, s/b between 2.0-3.0, prevent/treat DVT, afib, and heart valve replacements, vitamin K antagonist
|
COUMADIN
|
|
FDA approved 10/10, thrombin inhibitor, no labs needed, 150mg bid PO
|
PRADAXA
|